Symbols / PRE $19.96 +1.42% Prenetics Global Limited

Healthcare • Diagnostics & Research • Hong Kong • NGM
PRE Chart
About

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Diagnostics & Research Market Cap 335.90M
Enterprise Value 243.88M Income -52.70M Sales 92.39M
Book/sh 10.89 Cash/sh 4.57 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -29.35 PEG —
P/S 3.64 P/B 1.83 P/C —
EV/EBITDA -7.40 EV/Sales 2.64 Quick Ratio 2.76
Current Ratio 3.01 Debt/Eq 1.01 LT Debt/Eq —
EPS (ttm) -3.79 EPS next Y -0.68 EPS Growth —
Revenue Growth 248.60% Earnings 2026-05-12 ROA -11.02%
ROE -31.79% ROIC — Gross Margin 52.98%
Oper. Margin -33.27% Profit Margin -63.13% Shs Outstand 15.25M
Shs Float 12.36M Short Float 3.79% Short Ratio 1.72
Short Interest — 52W High 23.63 52W Low 3.10
Beta 0.27 Avg Volume 261.77K Volume 128.89K
Target Price $31.67 Recom Strong_buy Prev Close $19.68
Price $19.96 Change 1.42%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$31.67
Mean price target
2. Current target
$19.96
Latest analyst target
3. DCF / Fair value
$-72.00
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$19.96
Low
$29.00
High
$36.00
Mean
$31.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-16 init Lake Street — → Buy $29
2025-10-29 main Cantor Fitzgerald Overweight → Overweight $32
2025-01-16 reit Cantor Fitzgerald Overweight → Overweight $9
2024-12-04 reit Cantor Fitzgerald Overweight → Overweight $9
2024-04-04 main Cantor Fitzgerald Overweight → Overweight $9
News
RSS: Latest PRE news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
30.62
+40.83%
21.74
+65.17%
13.16
+5.04%
12.53
Operating Revenue
30.62
+40.83%
21.74
+65.17%
13.16
+5.04%
12.53
Cost Of Revenue
15.22
+17.87%
12.91
+35.27%
9.55
+6.90%
8.93
Reconciled Cost Of Revenue
15.22
+17.87%
12.91
+35.27%
9.55
+6.90%
8.93
Gross Profit
15.40
+74.41%
8.83
+144.06%
3.62
+0.43%
3.60
Operating Expense
66.29
+8.25%
61.23
-11.94%
69.53
+15.79%
60.05
Research And Development
10.92
-6.34%
11.66
+94.72%
5.99
-6.30%
6.39
Selling General And Administration
55.37
+11.44%
49.68
-22.47%
64.08
+19.40%
53.67
Selling And Marketing Expense
8.64
+4.77%
8.24
+73.98%
4.74
-17.44%
5.74
General And Administrative Expense
46.73
+12.77%
41.44
-30.17%
59.34
+23.81%
47.93
Other Gand A
46.73
+12.77%
41.44
-30.17%
59.34
+23.81%
47.93
Other Operating Expenses
—
-0.11
+79.81%
-0.54
-6644.83%
-0.01
Total Expenses
81.51
+9.93%
74.15
-6.24%
79.08
+14.64%
68.98
Operating Income
-50.89
+2.89%
-52.41
+20.50%
-65.92
-16.77%
-56.45
Total Operating Income As Reported
-48.14
+7.25%
-51.91
+21.38%
-66.02
-16.52%
-56.66
EBITDA
-51.57
-5.77%
-48.76
+77.64%
-218.04
-4.24%
-209.16
Normalized EBITDA
-44.31
-7.04%
-41.40
+65.97%
-121.67
+32.22%
-179.50
Reconciled Depreciation
5.93
-23.93%
7.79
+3.33%
7.54
+2.67%
7.35
EBIT
-57.50
-1.68%
-56.55
+74.93%
-225.58
-4.19%
-216.51
Total Unusual Items
-7.26
+1.33%
-7.35
+92.37%
-96.37
-224.81%
-29.67
Total Unusual Items Excluding Goodwill
-7.26
+1.33%
-7.35
+92.37%
-96.37
-224.81%
-29.67
Special Income Charges
1.24
+131.90%
-3.90
+95.64%
-89.55
-19019.31%
-0.47
Other Special Charges
—
—
89.55
—
Impairment Of Capital Assets
0.00
-100.00%
3.90
0.00
0.00
Restructuring And Mergern Acquisition
—
—
119.93
+102392.21%
-0.12
Write Off
—
0.00
0.00
-100.00%
0.18
Net Income
-46.30
+26.18%
-62.72
+67.07%
-190.45
-9.45%
-174.01
Pretax Income
-57.70
-1.82%
-56.67
+74.91%
-225.82
-4.28%
-216.55
Net Non Operating Interest Income Expense
1.84
-51.74%
3.80
+207.98%
-3.52
+30.26%
-5.05
Interest Expense Non Operating
0.20
+69.17%
0.12
-50.41%
0.24
+473.07%
0.04
Net Interest Income
1.84
-51.74%
3.80
+207.98%
-3.52
+30.26%
-5.05
Interest Expense
0.20
+69.17%
0.12
-50.41%
0.24
+473.07%
0.04
Interest Income Non Operating
2.04
-48.04%
3.92
+731.36%
0.47
+234725.87%
0.00
Interest Income
2.04
-48.04%
3.92
+731.36%
0.47
+234725.87%
0.00
Other Income Expense
-8.65
-7.20%
-8.07
+94.84%
-156.38
-0.86%
-155.05
Other Non Operating Income Expenses
0.39
+166.21%
0.14
+100.24%
-60.02
+52.13%
-125.38
Gain On Sale Of Security
-8.50
-146.09%
-3.45
+49.35%
-6.82
+76.65%
-29.20
Gain On Sale Of Business
1.24
0.00
0.00
+100.00%
-0.29
Tax Provision
-7.87
-2827.14%
-0.27
-9.80%
-0.24
-109.54%
2.57
Tax Rate For Calcs
0.00
+2774.66%
0.00
+337.51%
0.00
-99.34%
0.00
Tax Effect Of Unusual Items
-0.99
-2736.43%
-0.03
+66.61%
-0.10
+97.86%
-4.90
Net Income Including Noncontrolling Interests
-49.81
+23.11%
-64.78
+65.99%
-190.45
-9.45%
-174.02
Net Income From Continuing Operation Net Minority Interest
-46.33
+14.76%
-54.35
+75.91%
-225.58
-2.95%
-219.11
Net Income From Continuing And Discontinued Operation
-46.30
+26.18%
-62.72
+67.07%
-190.45
-9.45%
-174.01
Net Income Continuous Operations
-49.83
+11.65%
-56.40
+75.00%
-225.58
-2.95%
-219.12
Net Income Discontinuous Operations
0.02
+100.26%
-8.38
-123.85%
35.12
-22.13%
45.11
Minority Interests
3.50
+70.58%
2.05
0.00
-100.00%
0.01
Normalized Income
-40.06
+14.82%
-47.03
+63.63%
-129.31
+33.46%
-194.34
Net Income Common Stockholders
-46.30
+26.18%
-62.72
+67.07%
-190.45
-9.45%
-174.01
Diluted EPS
-3.71
+33.51%
-5.58
+85.12%
-37.50
-59.44%
-23.52
Basic EPS
-3.71
+33.51%
-5.58
+85.12%
-37.50
-59.44%
-23.52
Basic Average Shares
12.49
+11.10%
11.25
+121.84%
5.07
-31.48%
7.40
Diluted Average Shares
12.49
+11.10%
11.25
+121.84%
5.07
-31.48%
7.40
Diluted NI Availto Com Stockholders
-46.30
+26.18%
-62.72
+67.07%
-190.45
-9.45%
-174.01
Earnings From Equity Interest
-1.78
-107.10%
-0.86
0.00
0.00
Total Other Finance Cost
—
—
3.75
-25.09%
5.01
Line Item Trend 2024-12-31 2023-12-31
Total Assets
213.57
-15.97%
254.17
Current Assets
86.15
-8.02%
93.66
Cash Cash Equivalents And Short Term Investments
62.81
-13.65%
72.74
Cash And Cash Equivalents
52.25
+14.32%
45.71
Cash Financial
52.25
+14.32%
45.71
Other Short Term Investments
10.56
-60.93%
27.03
Receivables
5.61
+5.87%
5.29
Accounts Receivable
5.24
+29.18%
4.06
Gross Accounts Receivable
5.98
-7.71%
6.48
Allowance For Doubtful Accounts Receivable
-0.74
+69.47%
-2.42
Other Receivables
0.36
-67.24%
1.10
Inventory
6.57
+109.98%
3.13
Raw Materials
2.47
-0.08%
2.47
Work In Process
0.04
-56.73%
0.10
Finished Goods
4.05
+635.21%
0.55
Prepaid Assets
7.62
+81.92%
4.19
Current Deferred Assets
3.55
-57.31%
8.31
Total Non Current Assets
127.43
-20.61%
160.51
Net PPE
7.81
+35.19%
5.78
Gross PPE
26.91
+2.98%
26.13
Accumulated Depreciation
-19.10
+6.16%
-20.36
Properties
0.00
0.00
Machinery Furniture Equipment
7.06
-22.74%
9.14
Other Properties
14.21
+27.81%
11.12
Leases
5.64
-3.95%
5.88
Goodwill And Other Intangible Assets
48.94
+14.89%
42.59
Goodwill
37.36
+28.09%
29.17
Other Intangible Assets
11.57
-13.79%
13.43
Investments And Advances
69.33
-35.71%
107.84
Long Term Equity Investment
68.22
-30.71%
98.47
Non Current Deferred Assets
0.00
-100.00%
3.56
Non Current Deferred Taxes Assets
0.00
-100.00%
0.03
Non Current Prepaid Assets
1.35
+81.97%
0.74
Total Liabilities Net Minority Interest
42.23
-4.05%
44.01
Current Liabilities
36.55
-7.43%
39.48
Payables And Accrued Expenses
12.24
-25.29%
16.38
Payables
4.75
-54.05%
10.34
Accounts Payable
3.67
+119.51%
1.67
Other Payable
1.01
-18.48%
1.23
Current Accrued Expenses
7.48
+23.97%
6.04
Total Tax Payable
0.08
-98.95%
7.44
Current Debt And Capital Lease Obligation
2.76
+83.62%
1.50
Current Capital Lease Obligation
2.76
+83.62%
1.50
Current Deferred Liabilities
6.49
+6.22%
6.11
Current Deferred Revenue
6.49
+6.22%
6.11
Other Current Liabilities
15.07
-2.75%
15.49
Total Non Current Liabilities Net Minority Interest
5.68
+25.37%
4.53
Long Term Debt And Capital Lease Obligation
3.01
+247.64%
0.87
Long Term Capital Lease Obligation
3.01
+247.64%
0.87
Non Current Deferred Liabilities
2.17
-17.21%
2.62
Non Current Deferred Taxes Liabilities
2.17
-17.21%
2.62
Other Non Current Liabilities
0.32
-60.63%
0.82
Preferred Securities Outside Stock Equity
—
—
Stockholders Equity
170.39
-17.43%
206.36
Common Stock Equity
170.39
-17.43%
206.36
Capital Stock
0.02
+5.56%
0.02
Common Stock
0.02
+5.56%
0.02
Share Issued
12.98
+6.26%
12.22
Ordinary Shares Number
12.84
+5.24%
12.21
Treasury Shares Number
0.14
+889.74%
0.01
Additional Paid In Capital
857.33
+0.48%
853.20
Retained Earnings
-517.07
-9.84%
-470.77
Gains Losses Not Affecting Retained Earnings
-169.25
+3.85%
-176.03
Treasury Stock
0.64
+930.65%
0.06
Minority Interest
0.96
-74.81%
3.80
Other Equity Adjustments
-166.57
+4.18%
-173.83
Total Equity Gross Minority Interest
171.35
-18.47%
210.16
Total Capitalization
170.39
-17.43%
206.36
Working Capital
49.60
-8.45%
54.18
Invested Capital
170.39
-17.43%
206.36
Total Debt
5.77
+143.65%
2.37
Capital Lease Obligations
5.77
+143.65%
2.37
Net Tangible Assets
121.45
-25.84%
163.76
Tangible Book Value
121.45
-25.84%
163.76
Derivative Product Liabilities
0.17
-21.88%
0.22
Duefrom Related Parties Current
0.00
-97.81%
0.14
Dueto Related Parties Current
—
—
Financial Assets Designatedas Fair Value Through Profitor Loss Total
1.10
-88.23%
9.37
Foreign Currency Translation Adjustments
-2.68
-21.83%
-2.20
Investmentin Financial Assets
1.10
-88.23%
9.37
Investmentsin Associatesat Cost
68.22
+11157.92%
0.61
Investmentsin Joint Venturesat Cost
0.00
-100.00%
97.86
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-28.87
-109.76%
-13.77
-194.83%
14.52
+8.19%
13.42
Cash Flow From Continuing Operating Activities
-28.87
-109.76%
-13.77
-194.83%
14.52
+8.19%
13.42
Net Income From Continuing Operations
-49.81
+23.11%
-64.78
+65.99%
-190.45
-9.45%
-174.02
Depreciation Amortization Depletion
5.93
-23.93%
7.79
+3.33%
7.54
+2.67%
7.35
Depreciation
4.02
-31.69%
5.88
-1.80%
5.99
+39.62%
4.29
Amortization Cash Flow
1.91
-0.10%
1.92
+23.07%
1.56
-49.13%
3.06
Depreciation And Amortization
5.93
-23.93%
7.79
+3.33%
7.54
+2.67%
7.35
Amortization Of Intangibles
1.91
-0.10%
1.92
+23.07%
1.56
-49.13%
3.06
Other Non Cash Items
-1.84
+50.39%
-3.70
-110.85%
34.10
+566.53%
5.12
Stock Based Compensation
11.98
+13.12%
10.59
-91.26%
121.13
+438.46%
22.49
Asset Impairment Charge
1.29
-82.44%
7.37
+217.04%
2.32
+206.26%
0.76
Deferred Tax
-7.87
-1939.90%
-0.39
-105.40%
7.15
+91.47%
3.73
Deferred Income Tax
-7.87
-1939.90%
-0.39
-105.40%
7.15
+91.47%
3.73
Operating Gains Losses
0.61
+171.16%
-0.85
+70.67%
-2.91
-41243.18%
0.01
Gain Loss On Investment Securities
-0.05
+98.54%
-3.35
-4.49%
-3.21
—
Unrealized Gain Loss On Investment Securities
8.87
+24.30%
7.13
-89.73%
69.45
-55.06%
154.55
Net Foreign Currency Exchange Gain Loss
0.12
-85.51%
0.82
+263.27%
0.23
+179.29%
-0.29
Gain Loss On Sale Of PPE
0.00
-99.76%
0.82
+1020.55%
0.07
+187279.49%
-0.00
Change In Working Capital
1.97
-91.88%
24.21
+171.71%
-33.76
-412.23%
-6.59
Change In Receivables
-0.43
-101.14%
37.50
+437.58%
6.97
+128.99%
-24.06
Changes In Account Receivables
-0.56
-101.50%
37.63
+440.24%
6.97
+128.96%
-24.05
Change In Inventory
1.32
+176.52%
-1.73
-237.66%
1.26
+153.87%
-2.33
Change In Prepaid Assets
-2.11
-232.66%
1.59
+230.89%
-1.21
+80.18%
-6.13
Change In Payables And Accrued Expense
-3.83
+70.63%
-13.04
+51.75%
-27.02
-213.07%
23.89
Change In Accrued Expense
0.85
+111.51%
-7.42
+69.59%
-24.39
-189.17%
27.35
Change In Payable
-4.68
+16.66%
-5.62
-113.77%
-2.63
+23.99%
-3.46
Change In Account Payable
-4.68
+16.66%
-5.62
-113.77%
-2.63
+23.99%
-3.46
Change In Other Working Capital
8.67
+1761.69%
-0.52
+96.50%
-14.92
-689.10%
2.53
Change In Other Current Assets
-0.43
-179.81%
0.54
+24.13%
0.43
+186.21%
-0.50
Change In Other Current Liabilities
-1.24
-900.81%
-0.12
-117.08%
0.73
0.00
Investing Cash Flow
38.54
+146.46%
-82.95
-79.76%
-46.15
-109.54%
-22.02
Cash Flow From Continuing Investing Activities
38.54
+146.46%
-82.95
-79.76%
-46.15
-109.54%
-22.02
Net PPE Purchase And Sale
-0.96
-291.87%
-0.25
+94.98%
-4.90
+37.47%
-7.83
Purchase Of PPE
-1.01
-191.59%
-0.34
+93.03%
-4.95
+42.11%
-8.55
Sale Of PPE
0.04
-57.58%
0.10
+98.00%
0.05
-92.99%
0.71
Capital Expenditure
-1.06
-16.78%
-0.91
+85.62%
-6.34
+44.42%
-11.41
Net Investment Purchase And Sale
15.87
+360.95%
-6.08
+83.52%
-36.91
-269.15%
-10.00
Purchase Of Investment
-0.13
+99.50%
-26.00
+34.86%
-39.92
-299.20%
-10.00
Sale Of Investment
16.00
-19.68%
19.92
+562.90%
3.00
0.00
Net Business Purchase And Sale
21.65
+127.07%
-80.00
-2239.87%
-3.42
0.00
Purchase Of Business
-8.35
+89.57%
-80.00
-2239.87%
-3.42
0.00
Gain Loss On Sale Of Business
-1.24
0.00
0.00
-100.00%
0.29
Net Intangibles Purchase And Sale
-0.06
+89.59%
-0.57
+59.35%
-1.40
+51.31%
-2.87
Purchase Of Intangibles
-0.06
+89.59%
-0.57
+59.35%
-1.40
+51.31%
-2.87
Net Other Investing Changes
—
—
—
-1.33
Financing Cash Flow
-3.34
+28.93%
-4.70
-103.28%
143.32
+388.86%
29.32
Cash Flow From Continuing Financing Activities
-3.34
+28.93%
-4.70
-103.28%
143.32
+388.86%
29.32
Net Issuance Payments Of Debt
-2.56
+20.77%
-3.23
-72.26%
-1.88
-44.57%
-1.30
Issuance Of Debt
0.00
0.00
-100.00%
21.68
0.00
Repayment Of Debt
-2.56
+20.77%
-3.23
+86.27%
-23.55
-1713.27%
-1.30
Long Term Debt Issuance
0.00
0.00
-100.00%
21.68
0.00
Long Term Debt Payments
-2.56
+20.77%
-3.23
+86.27%
-23.55
-1713.27%
-1.30
Net Long Term Debt Issuance
-2.56
+20.77%
-3.23
-72.26%
-1.88
-44.57%
-1.30
Net Common Stock Issuance
-0.58
+53.01%
-1.23
-125.32%
-0.55
0.00
Common Stock Payments
-0.58
+53.09%
-1.23
-85.80%
-0.66
0.00
Cash Dividends Paid
0.00
0.00
0.00
0.00
Repurchase Of Capital Stock
-0.58
+53.09%
-1.23
-85.80%
-0.66
0.00
Net Other Financing Charges
—
—
146.16
+2912.37%
4.85
Changes In Cash
6.32
+106.24%
-101.42
-190.81%
111.69
+439.25%
20.71
Effect Of Exchange Rate Changes
0.22
-52.68%
0.47
+247.32%
-0.32
-463.48%
0.09
Beginning Cash Position
45.71
-68.84%
146.66
+315.60%
35.29
+143.54%
14.49
End Cash Position
52.25
+14.32%
45.71
-68.84%
146.66
+315.60%
35.29
Free Cash Flow
-29.94
-103.99%
-14.68
-279.60%
8.17
+307.74%
2.00
Common Stock Issuance
0.00
-100.00%
0.00
-98.29%
0.12
0.00
Dividends Received CFI
0.00
0.00
-100.00%
0.01
0.00
Earnings Losses From Equity Investments
1.78
+107.10%
0.86
0.00
0.00
Interest Paid CFF
-0.20
+15.77%
-0.24
+42.21%
-0.42
-102.48%
-0.21
Interest Received CFI
2.04
-48.29%
3.94
+735.38%
0.47
+11759.30%
0.00
Issuance Of Capital Stock
0.00
-100.00%
0.00
-98.29%
0.12
-99.55%
25.97
Net Preferred Stock Issuance
—
0.00
0.00
-100.00%
25.97
Preferred Stock Issuance
—
0.00
0.00
-100.00%
25.97
Sale Of Business
30.00
0.00
0.00
0.00
Taxes Refund Paid
0.00
+100.00%
-1.14
-1806.67%
-0.06
-395.80%
0.02
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category